trial

fda-approves-first-human-trial-for-blueberry-sized-brain-implant-targeting-treatment-resistant-depression

FDA Approves First Human Trial for Blueberry-Sized Brain Implant Targeting Treatment-Resistant Depression

Dzikria Novita May 3, 2026

The United States Food and Drug Administration has officially granted approval for the first...

an-experimental-gene-targeted-therapy-for-dravet-syndrome-shows-remarkable-safety-and-efficacy-in-pioneering-clinical-trial

An Experimental Gene-Targeted Therapy for Dravet Syndrome Shows Remarkable Safety and Efficacy in Pioneering Clinical Trial

Nila Kartika Wati March 26, 2026

An investigational therapy, zorevunersen, designed to address the underlying genetic cause of Dravet syndrome,...